GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for nicotinamide-nucleotide adenylyltransferase (Q97AF1)

Analyse AlphaFold monomer V2.0 prediction for nicotinamide-nucleotide… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q97AF1
Type
protein
Length
178 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xbDA05C32aD6eE153C8C5A78dfa48d7Ba25694fea
Molecule
Nicotinamide-nucleotide adenylyltransferase
UniProt
Q97AF1
Pockets
1 · best druggability 0.63

Structure

1 distinct chain · 43% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANicotinamide-nucleotide adenylyltransferaseprotein17843% helix, 13% strandQ97AF1

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13190.630.7936empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.